XML 84 R74.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK-BASED COMPENSATION - Fair Value and Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Option Plan Shares      
Valuation assumptions      
Risk-free interest rates, minimum (as a percent)   0.11%  
Risk-free interest rates, maximum (as a percent)   1.47%  
Expected volatility, minimum (as a percent)   44.19%  
Expected volatility, maximum (as a percent)   77.51%  
Dividend yield (as a percent)   0.00%  
Aggregate Intrinsic Value      
Weighted average fair value per share of options granted during the period (in dollars per share)   $ 58.57  
Option Plan Shares | Minimum      
Valuation assumptions      
Expected term (in years)   3 months  
Option Plan Shares | Maximum      
Valuation assumptions      
Expected term (in years)   6 years 1 month 24 days  
Restricted Shares and RSUs      
Restricted Shares, RSUs, and Performance Share Units      
Outstanding at the beginning of the period (in shares) 3,968,214    
Granted (in shares) 2,084,705    
Assumed through acquisition (in shares) 242,123    
Released (in shares) (1,582,760)    
Forfeited (in shares) (406,201)    
Outstanding at the end of the period (in shares) 4,306,081   3,968,214
Weighted Average Grant Date Fair Value      
Outstanding at the beginning of the period (in dollars per share) $ 79.50    
Granted (in dollars per share) 133.80    
Assumed through acquisition (in dollars per share) 127.79    
Released (in dollars per share) 72.28    
Forfeited (in dollars per share) 99.94    
Outstanding at the end of the period (in dollars per share) $ 109.23   $ 79.50
Fair value of equity instruments other than options vested in period $ 114,400 $ 79,100  
Restricted Stock Units      
Weighted Average Grant Date Fair Value      
Granted (in dollars per share)   $ 90.95  
Performance Share Units      
Restricted Shares, RSUs, and Performance Share Units      
Outstanding at the beginning of the period (in shares) 618,515    
Granted (in shares) 253,120    
Released (in shares) 0    
Forfeited (in shares) (8,991)    
Outstanding at the end of the period (in shares) 862,644   618,515
Weighted Average Grant Date Fair Value      
Outstanding at the beginning of the period (in dollars per share) $ 93.22    
Granted (in dollars per share) 140.96 $ 90.17  
Released (in dollars per share) 0    
Forfeited (in dollars per share) 68.23    
Outstanding at the end of the period (in dollars per share) $ 107.49   $ 93.22
Number of outstanding performance share units (in shares) 249,695    
Employee stock      
Valuation assumptions      
Risk-free interest rates, minimum (as a percent) 0.04% 0.12%  
Risk-free interest rates, maximum (as a percent) 0.16% 0.20%  
Expected volatility, minimum (as a percent) 48.38% 63.67%  
Expected volatility, maximum (as a percent) 68.51% 89.04%  
Dividend yield (as a percent) 0.00% 0.00%  
Employee stock | Minimum      
Valuation assumptions      
Expected term (in years) 6 months 6 months  
Employee stock | Maximum      
Valuation assumptions      
Expected term (in years) 2 years 2 years  
Stock Plans      
Shares      
Outstanding at the beginning of the period (in shares) 2,231,059    
Granted (in shares) 0    
Assumed through acquisition (in shares) 1,393,748    
Exercised (in shares) (1,208,355)    
Forfeited (in shares) (36,909)    
Outstanding at the end of the period (in shares) 2,379,543   2,231,059
Vested and expected to vest at end of period (in shares) 2,379,543    
Exercisable at the end of the period (in shares) 1,816,492    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 39.67    
Granted (in dollars per share) 0    
Assumed through acquisition (in dollars per share) 5.51    
Exercised (in dollars per share) 11.09    
Forfeited (in dollars per share) 62.85    
Outstanding at the end of the period (in dollars per share) 33.81   $ 39.67
Vested and expected to vest at end of period (in dollars per share) 33.81    
Exercisable at the end of the period (in dollars per share) $ 25.17    
Weighted Average Remaining Contractual Term      
Outstanding 5 years 7 months 6 days   6 years
Vested and expected to vest at end of period 5 years 7 months 6 days    
Exercisable at the end of the period 4 years 10 months 24 days    
Aggregate Intrinsic Value      
Outstanding at the end of the period $ 147,337    
Vested and expected to vest at end of period 147,337    
Exercisable at the end of the period 127,826    
Total intrinsic value of options exercised $ 148,800 $ 29,000